17/06/13: SureFISH for FFPE Samples

June 17, 2013 by  

SureFISH Banner_FFPE

Agilent have now updated their SureFISH manual to include recommendations for formalin fixed paraffin embedded (FFPE) samples.

Check out the updated protocol here. (opens a PDF file)

17/06/13: HaloPlex Disease Research Panels Overview & Demonstration Webinar

June 17, 2013 by  

Webinar_researcher

Join Agilent’s webinar on Tuesday, June 18, 2013 5:00 pm. Crikey, that is already tomorrow! Well, if you are interested, here is a preview:

The ability to detect sequence level variations through next generation sequencing in a fast, cost effective application has revolutionized the field of genetics. In order to harness the power of next generation sequencing for specific disease states, it is critical to target these specific genomic regions. Developed in conjunction with clinical research industry leaders, Agilent Technologies offers HaloPlex next generation sequencing target enrichment panels for researching specific genetic disorders.

Agilent’s integrated solution for clinical genomics research also includes SureCall, an easy-to-use desktop application that combines best in class open source algorithms for end-to-end NGS data analysis from alignment to categorization of mutations. With this complete workflow, customers can rapidly deploy studies for clinical research.

 

If you are interested, please Register Here!

 

 

17/06/13: Introducing HaloPlex Disease Research Panels

June 17, 2013 by  

DNA sequencing cancer

Great news!  I’m excited that Agilent have launched HaloPlex Disease Research panels recently (official launch at ESHG 2013)!  The panels are a series of 7 comprehensive panels developed in collaboration with clinical research experts, focusing on targeted gene sets for specific disease research applications. All panels should provide premium coverage and performance for accurate and reliable variant calling.

Agilent offers two catalog HaloPlex panels, the Cancer Research Panel and the Cardiomyopathy panel.

In addition, pre-designed panels for other disease gene sets are available in SureDesign and can be ordered as custom designs.

Below is a summary of what is available with this launch

haloPlex Clinical Research Panels

30/05/13: Cool! IDT Now Offer qPCR Assay Plates

May 30, 2013 by  

bigstock-PCR-multiwell-plate-40743283

I think that this is a great new release by Integrated DNA Technologies (IDT, www.idtdna.com).

It’s been a long-awaited release. IDT has announced the launch of PrimeTime® qPCR Assay Plates, for high throughput qPCR analysis. Primers and probes for 5’-nuclease and intercalating dye assays (e.g., SYBR®) can now be directly ordered online in a 96 well plate format, eliminating the time-consuming transfer of primers and probes from reagent stocks, and streamlining the reaction set-up. PrimeTime qPCR Assay Plates offer an ideal solution for many applications that generate large quantities of data, such as validation of NGS and microarray data, as well as high throughput gene expression screening.

Addressing the needs of each particular qPCR assay requirement, a range of primer and/or probe concentrations are available, delivered lyophilized within a 96 deep-well plate. For additional flexibility, different dye-quencher combinations can also be ordered on the same plate, extending the range of assays that can be performed during a single run. The researcher does not even need to purchase a complete 96 well plate, just 24 assays is the minimum per plate order. Further cost savings are possible once a plate layout has been designed, since replicate plates can be generated at a lower total cost per reaction, making this format particularly suited to high throughput applications in academia and industry.

Designing and ordering your custom assays in this new plate format is rapid and intuitive with the online PrimeTime® qPCR assay tool, which allows users to easily create a master plate via simple copy and paste actions from source data. Alternatively, researchers can select from a specialized library of predesigned human, mouse, or rat assays generated by IDT’s sophisticated design engine. In addition to incorporating accurate Tm and secondary structure prediction data, this assay design engine takes into account the latest data from the NCBI RefSeq database, to avoid off- target amplification and SNPs, thus ensuring maximum assay performance.

As standard, IDT ensures the highest quality oligonucleotide synthesis, with full QC assessment by mass spectrometry, and results available free of charge on our website.

For more information, please visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.

29/05/13: iGEM 2013 Special Offer from IDT

May 29, 2013 by  

iGEM promo synthetic Biology IDT

Integrated DNA Technologies (IDT) is proud to be an iGEM Corporate Sponsor for 2013. IDT are also partnering with iGEM 2013 teams to help them achieve their goals. This year IDT are offering 50% off gBlocks® Gene Fragments. Learn more at this link

Any iGEM teams in Denmark and Sweden who are interested in help, please contact me via the contact page.

Next Page »

Switch to our mobile site

divider